Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Cue Biopharma, Inc. (CUE) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$21.94M |
|
$1.58M |
|
-- |
|
$21.94M |
|
$19.96M |
|
$1.98M |
|
$0.11M |
|
$2.08M |
|
$2.08M |
|
$1.58M |
|
$1.58M |
|
$1.58M |
|
$1.58M |
|
$1.98M |
|
$2.63M |
|
94.73M |
|
94.73M |
|
$0.05 |
|
$0.05 |
|
| Balance Sheet Financials | |
$36.98M |
|
$0.24M |
|
$5.23M |
|
$42.21M |
|
$13.49M |
|
-- |
|
$2.29M |
|
$15.78M |
|
$26.43M |
|
$26.43M |
|
$26.43M |
|
96.62M |
|
| Cash Flow Statement Financials | |
$-21.69M |
|
$0.07M |
|
$26.29M |
|
$22.61M |
|
$27.29M |
|
$4.68M |
|
$4.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.74 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
9.01% |
|
9.01% |
|
-- |
|
9.50% |
|
7.22% |
|
$-21.82M |
|
-- |
|
-- |
|
-- |
|
0.52 |
|
-- |
|
3.96 |
|
22.75 |
|
6.00% |
|
6.00% |
|
3.75% |
|
6.00% |
|
$0.27 |
|
$-0.23 |
|
$-0.23 |
|